The "Cartes d'Identité des Tumeurs (CIT)" program, launched and funded by the French charity "Ligue Nationale contre le Cancer," aims to improve or develop better targeted therapeutic approaches by refining molecular knowledge of multiple types of tumors. The CIT program mainly relies on the large-scale and systematic profiling of large cohorts of tumors at various molecular levels including at least the genome, the epigenome, and the transcriptome.

See also

References

    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.